As a 501(c)(3) nonprofit, we depend almost entirely on donations from people like you.
We really need your help to continue this work! Please consider making a donation.
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

GlaxoSmithKline (GSK) Fined $488.8 Million for 'Massive Bribery Network' in China
Key Excerpts from Article on Website of ABC News


ABC News, September 19, 2014
Posted: September 26th, 2014
http://abcnews.go.com/International/glaxosmithkline-gsk-fine...

China has fined the British pharmaceuticals giant GlaxoSmithKline (GSK) $488.8 million (3 billion Yuan) for a "massive bribery network" to get doctors and hospitals to use its products. Five former employees were sentenced to two to four years in jail, but ordered deported instead of imprisoned, according to state news agency Xinhua today. The fine was the biggest ever imposed by a Chinese court. The court gave Mark Reilly, former head of GSK Chinese operations, a three-year prison sentence with a four-year reprieve, which meant he is set to be deported instead of serving his time in a Chinese jail. Reilly was accused of operating a massive bribery network in May. The police said it is believed Reilly authorized his salespeople to pay doctors, hospital officials and health institutions to use GSKs products since 2009. Throughout 2012 a stream of anonymous emails alleging bribery authorized by senior staff at GSK were sent to Chinese regulators. At the beginning of 2013, the anonymous emails began to arrive at GSK headquarter in London, along with a sex tape of Mark Reilly and his Chinese girlfriend. The charges claim that GSK hired Shanghai-based investigator Peter Humphrey and his American wife, Yu Yingzeng, to locate the whistleblower. The Humphreys were detained and charged with illegally obtaining phone logs, travel records and other data which then they put in a report to GSK. GSK released a statement of apologies to the Chinese government and people on its website. "GSK Plc has reflected deeply and learned from its mistakes, has taken steps to comprehensively rectify the issues identified at the operations of GSKCI, and must work hard to regain the trust of the Chinese people," the statement said.

Note: For more on this, see concise summaries of deeply revealing health news articles from reliable major media sources.


Latest News


Key News Articles from Years Past